Benefits of two doses of COVID-19 vaccine in 12- to 17-year-olds outweigh risks, study finds

The benefits of giving children aged 12 to 17 years two doses of the COVID-19 vaccine ‘clearly outweighs the risks’, given the current high case rate, according to a new study.